We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,496

The Next Generation ACO Model
  • McDermott Will & Emery
  • USA
  • March 30 2015

On March 10, 2015, the Centers for Medicare and Medicaid Services (CMS) introduced its latest accountable care initiative, the Next Generation ACO


New HIPAA Privacy Rule Permits Disclosures to Background Check System
  • McDermott Will & Emery
  • USA
  • January 13 2016

On January 6, 2016, the U.S. Department of Health and Human Services (HHS) issued a final rule amending the Health Insurance Portability and


CMS releases broad data on prescribing patterns of physicians and providers under Medicare Part D
  • McDermott Will & Emery
  • USA
  • May 21 2015

In a highly anticipated and scrutinized decision, the Centers for Medicare & Medicaid Services (CMS) released a new public data set on April 30, 2015


Update on state breach notification laws
  • McDermott Will & Emery
  • USA
  • April 14 2015

In the first few months of 2015, a number of states have introduced data breach notification bills and proposed legislative amendments designed to


Recent DOJ enforcement actions demonstrate that the focus on mental health services fraud continues
  • McDermott Will & Emery
  • USA
  • May 20 2015

Two recent actions announced by the U.S. Department of Justice (DOJ), one civil and one criminal, along with a recent speech by Assistant Attorney


Increased federal scrutiny of laboratory-physician arrangements for potential AKS and FCA violations leads to $48.5 million settlement
  • McDermott Will & Emery
  • USA
  • April 15 2015

A recent $48.5 million False Claims Act (FCA) settlement between two laboratory companies and the federal government highlights the increased


PTAB findings get lots of deference
  • McDermott Will & Emery
  • USA
  • September 30 2015

In a non-precedential opinion, the U.S. Court of Appeals for the Federal Circuit heavily deferred to the factual findings of the Patent Trial and


Tax Court decision in Altera overturns important transfer pricing regulations
  • McDermott Will & Emery
  • OECD, USA
  • October 3 2015

On July 27, 2015, the U.S. Tax Court issued a stunning rebuke to the IRS by invalidating the part of the Internal Revenue Services’ (IRS


New OIG reports peg billing trends and prescribing hotspots as harbingers of Part D fraud
  • McDermott Will & Emery
  • USA
  • June 30 2015

On Tuesday, June 23, the U.S. Department of Health & Human Services Office of Inspector General (OIG) released two reports that hone in on data


Claimed formulation not obvious despite recitations falling within prior art ranges
  • McDermott Will & Emery
  • USA
  • September 30 2015

Addressing obviousness issues, the U.S. Court of Appeals for the Federal Circuit affirmed a lower court’s finding that patents were valid and